Distribution of spreading viruses during COVID-19 pandemic: Effect of mitigation strategies.
Distribution of spreading viruses during COVID-19 pandemic: Effect of mitigation strategies.
复制标题
DOI：
10.1016/j.ajic.2021.06.002
复制
发表时间：
2021-09
影响因子：
4.9
通讯作者：
Devrim İ
中科院分区：
文献类型：
--
作者：
Kıymet E;Böncüoğlu E;Şahinkaya Ş;Cem E;Çelebi MY;Düzgöl M;Kara AA;Arıkan KÖ;Aydın T;İşgüder R;Yılmazer MM;Ayhan Y;Gülfidan G;Bayram A;Bayram N;Çelik T;Alp YT;Devrim İ
The study aimed to evaluate the distribution of circulating respiratory viral pathogens other than severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during the first year of the coronavirus disease-2019 (COVID-19) pandemic with especially focusing on the effects of the national-based mitigation strategies. This single-center study was conducted between March 11, 2020-March 11, 2021. All children who were tested by polymerase chain reaction on nasopharyngeal swabs for SARS-CoV-2 and other common respiratory viral pathogens were included in the study. A total of 995 children with suspected COVID-19 admitted to the study center. Of these, 513 patients who were tested by polymerase chain reaction for both SARS-CoV-2 and common respiratory viral pathogens were included in the final analysis. Two hundred ninety-five patients were (57.5%) male. The median age was 3 years of age (27 days-17 years). A total of 321 viral pathogens identified in 310 (n: 310/513, 60.4%) patients, and 11 of them (n: 11/310, 3.5%) had co-detection with more than 1 virus. The most common detected virus was rhinovirus (n: 156/513, 30.4%), and SARS-CoV-2 (n: 122/513, 23.8%) followed by respiratory syncytial virus (n: 18/513, 3.5%). The influenza virus was detected in 2 patients (0.4%). A total of 193 patients were negative for both SARS-CoV-2 and other pathogens. There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic.
登录
查看更多内容
DOI：
10.1007/s42399-021-00913-4
发表时间：
2021
期刊：
SN comprehensive clinical medicine
影响因子：
--
作者：
Cimolai N
通讯作者：
Cimolai N
影响因子：
4.5
作者：
Zhang DD;Acree ME;Ridgway JP;Shah N;Hazra A;Ravichandran U;Kumar M
通讯作者：
Kumar M
影响因子：
168.9
作者：
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者：
Cao, Bin
影响因子：
12.7
作者：
Ding, Qiang;Lu, Panpan;Liu, Mei
通讯作者：
Liu, Mei
DOI：
10.1001/jama.2020.6775
发表时间：
2020-01-01
期刊：
JAMA, Journal of the American Medical Association
影响因子：
--
作者：
Richardson, Safiya;Hirsch, Jamie S.;,
通讯作者：
,